ductal carcinoma in situ Some Recurrent Disease Following Ductal Carcinoma In Situ Unrelated to Initial Lesions, Study Finds The finding contrasts with the previous thought that most later recurrences arise from the original ductal carcinoma in situ lesion. Stanford Team Uses Ionpath's MIBI Tech to Determine DCIS Risk Level Premium The team's findings suggest that low-risk DCIS lesions may trigger an immune response that could be protective against future invasive breast cancer. Researchers ID Genomic Signature to Risk Stratify Patients With Precancerous Breast Lesions In the study, presented at SABCS, researchers developed an 812-gene signature that could identify which patients with ductal carcinoma in situ need aggressive treatment. PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ. PreCancer Atlas Attempts to Push Precision Medicine to Early-Stage Disease Premium Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form. May 22, 2019 PreludeDx Receives New York State Approval for DCIS Test Jan 4, 2018 Topographic Single-Cell Sequencing Method Yields New Insights in Breast Cancer Evolution Premium Aug 6, 2015 Genomic Health Publishes Second Study on Prostate Test, Expects Medicare Reimbursement by Q4 Premium Aug 4, 2015 Genomic Health Posts Flat Q2 Revenues, Misses Wall Street Estimates Dec 12, 2014 Researchers Present Data from Second Validation Study of Genomic Health Oncotype DX DCIS Test Nov 5, 2014 Genomic Health Reports 5 Percent Revenue Growth in Third Quarter Aug 13, 2014 Genomic Health Focused on Validating, Driving Adoption of Prostate Cancer, DCIS Tests Premium Aug 7, 2014 Genomic Health Reports 11 Percent Revenue Jump in Second Quarter Sep 23, 2013 Analyst Downgrades Genomic Health to Underperform May 13, 2013 Medicare to Cover Genomic Health's Oncotype DX Breast Cancer Test for DCIS May 8, 2013 With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise Premium Mar 13, 2013 Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy Premium Feb 13, 2013 After 14 Percent Revenue Bump in 2012, Genomic Health Focusing on Market Growth, Prostate Dx Launch Premium Nov 14, 2012 Genomic Health Attributes Q3 Revenue Growth to Strong International Test Adoption Premium May 9, 2012 Genomic Health Partners with OncoMed to Grow Companion Dx, NGS Reach Premium Jan 9, 2012 Genomic Health Expanding Sales Force by 20 Percent; Starts Prostate Dx Studies Nov 2, 2011 Myriad Reports 20 Percent Q1 Revenue Growth, Rising Demand for Colorectal Cancer Test Premium Aug 10, 2011 Genomic Health Focuses on Oncotype DX Tests for DCIS and Colon Cancer for Future Growth Premium Feb 16, 2011 After Profitable Year, Genomic Health to Invest in New Products, Overseas Market, Next-Gen Sequencing Premium Sep 29, 2010 Genomic Health Updates Investors on Timeline for DCIS, Colon Cancer, Prostate Cancer Tests Premium Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.